Abstract
Background The Tape Locking Screw (TLS®) system for anterior cruciate ligament reconstruction (ACLR) is an emerging short graft with tape suspension (SGTS) technique which uses a single hamstring tendon with tape suspension and dedicated interference screw fixation. Few studies have examined the SGTS technique versus other techniques. The objective of this study was to compare LOE in patients undergoing ACLR with the SGTS technique with other ACLR techniques. We hypothesised that the SGTS technique would be superior to others in terms of minimising LOE.
Materials and methods We retrospectively reviewed 138 patients who received primary ACLR between January 2015 and December 2017 and had elected to participate in a rehabilitation program with the hospital physiotherapy department had postoperative knee extension assessed. Patients were followed up by a department physiotherapist until baseline function was achieved. Patients were grouped as having either SGTS ACLR or non-SGTS ACLR during chart review and compared for LOE at initial assessment and when the maximum extension had been achieved.
Results There were 44 patients in the SGTS group and 94 patients in the non-SGTS group. The SGTS group had a significantly larger median graft diameter (8.5mm vs. 8.0mm, P <0.001) and less incidence of notchplasty (17.8% vs. 44.7%, P <0.001). LOE incidence was significantly associated with the use of notchplasty and graft type at initial assessment. At the time of maximum extension, LOE incidence was significantly associated with LOE at initial assessment, graft size, graft type and lateral meniscus injury. Time to maximum extension was significantly associated with the presence of LOE at initial assessment.
Conclusion In this retrospective analysis, the SGTS technique was not inferior to other ACLR techniques with respect to postoperative loss of extension. Longer time to achieve full extension in the SGTS group was not considered clinically significant. Further studies are needed to assess longer term success and functional outcomes.
Competing Interest Statement
Corey Scholes holds shares in EBM Analytics, which is contracted to perform registry activities for QEII Jubilee Orthopaedics. No other authors have conflicts of interest to disclose.
Funding Statement
This study was funded in full by the Queen Elizabeth II Jubilee Orthopaedic Research Fund.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Blinded data may be available from the authors at reasonable request.
